+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Contract Dose Manufacturing"

Unit Dose Manufacturing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Unit Dose Manufacturing Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Tablet & Capsule Counter Market - Global Forecast 2026-2032 - Product Thumbnail Image

Tablet & Capsule Counter Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
From
Unit Dose Manufacturing Market - Global Strategic Business Report - Product Thumbnail Image

Unit Dose Manufacturing Market - Global Strategic Business Report

  • Report
  • February 2026
  • 375 Pages
  • Global
From
Allogeneic Cell Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Allogeneic Cell Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Unit Dose Manufacturing Market Report 2025 - Product Thumbnail Image

Unit Dose Manufacturing Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator

Contract dose manufacturing is a service provided by pharmaceutical companies to produce drugs and other pharmaceutical products. It involves the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for customers. Contract dose manufacturing is a cost-effective way for pharmaceutical companies to outsource the production of their products. It also allows them to focus on their core competencies, such as research and development, while leaving the manufacturing to a third-party. Contract dose manufacturing is a highly regulated process, with strict quality control measures in place to ensure the safety and efficacy of the products. Some of the companies in the contract dose manufacturing market include Boehringer Ingelheim, Catalent, Lonza, Patheon, Recipharm, and Vetter. Show Less Read more